Categories: Automobile

Kia America to Unveil Five New Vehicles at Upcoming Los Angeles Auto Show

Kia applies Opposites United design philosophy across multiple car lines

Next week, Kia America will debut five new vehicles at the 2024 Los Angeles Auto Show. Across multiple car lines, the show will play host to the debut of ICE, HEV, PHEV and EV Kia models brimming with new design elements, upgraded performance and Kia’s latest connectivity technology.

The Opposites United design iconography was first introduced on the EV6 in early 2021 and has since grown to encompass multiple new vehicles from Kia. It was most recently highlighted during the global debut of the production version of the EV3 and will eventually course through every upcoming model from the South Korean mobility brand.

“With five vehicles to unveil at next week’s Los Angeles Auto Show, we want it to be made very clear that Kia is driving forward on all fronts,” said Steven Center, COO & EVP, Kia America. “We are going to pull the wraps off some of the most important elements of our award-winning portfolio and we believe our customers will be delighted at what’s coming to our showrooms in the very near future.”

- Advertisement -

The Kia press conference is scheduled to take place November 21 at 9:45 AM, Pacific Time, and consumers can experience the event in real time by tuning into the livestream at Kia.com.  

TheNews Market

Recent Posts

KFSHRC Madinahs Virtual Clinics Wins Award at PX Congress

RIYADH, Saudi Arabia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research…

4 hours ago

IBA Business Update Third Quarter 2024

Louvain-la-Neuve, Belgium, 21 November 2024 - IBA (Ion Beam Applications S.A), the world leader in…

4 hours ago

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR…

4 hours ago

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

– Kura to receive a $330 million upfront payment and up to $1.2 billion in…

4 hours ago

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Revuforj (revumenib)

LOUISVILLE, Ky., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy,…

4 hours ago

Las Vegas Unveils Exclusive Entertainment, Packages and More for Race Week 2024

Destination Revving up This Year’s Excitement with Top-Tier Entertainment, Luxurious Trackside Experiences and Celebrations like…

7 hours ago